Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,037,087
Closed -$20M 85
2025
Q2
$20M Buy
2,037,087
+526,589
+35% +$4.36M 3.69% 10
2025
Q1
$11M Buy
1,510,498
+1,413,987
+1,465% +$12.4M 2.25% 16
2024
Q4
$755K Buy
96,511
+4,213
+5% +$34.7K 0.17% 56
2024
Q3
$683K Hold
92,298
0.15% 63
2024
Q2
$739K Hold
92,298
0.17% 60
2024
Q1
$1.07M Sell
92,298
-66,421
-42% -$735K 0.3% 59
2023
Q4
$1.77M Buy
158,719
+98,472
+163% +$905K 0.53% 50
2023
Q3
$930K Sell
60,247
-336,250
-85% -$5.64M 0.28% 60
2023
Q2
$7.51M Sell
396,497
-41,718
-10% -$733K 2.32% 12
2023
Q1
$6.67M Buy
+438,215
New +$5.71M 2.76% 11
2022
Q4
Sell
-250,000
Closed -$1.45M 94
2022
Q3
$1.45M Buy
+250,000
New +$1.1M 0.49% 54
2021
Q3
Sell
-28,032
Closed -$524K 91
2021
Q2
$524K Sell
28,032
-21,975
-44% -$491K 0.23% 80
2021
Q1
$1.18M Buy
50,007
+6,000
+14% +$138K 0.65% 52
2020
Q4
$1.07M Buy
+44,007
New +$1.13M 0.62% 48

Other funds holding ETNB

Silverarc Capital Management's ETNB Position: Q3 2025 in Review

Silverarc Capital Management sold out of 89bio (ETNB) in Q3 2025, closing a stake of 2,037,087 shares — an estimated $20M sold.

Silverarc Capital Management first reported a position in ETNB in Q4 2020 and held it in 14 quarters. The position peaked at $20M in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Silverarc Capital Management reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Silverarc Capital Management sold 2,037,087 89bio shares in Q3 2025, an estimated $20M.
  • Silverarc Capital Management first reported a position in 89bio in Q4 2020 and held it in 14 quarters.
  • Silverarc Capital Management's 89bio position peaked at $20M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Silverarc Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.